News & Analysis on Clinical Trial Services & Contract Research And Development
Editors of eleven international medical journals have amplified their call for the registration of drug trials before the first patient is enrolled,in a medium that is fully searchable and publicly accessible at no charge.
The primary difficulty facing anyone given the task of designing a state-of-the-art laboratory is that they generally don't have access to a crystal ball to tell them exactly what will be at the leading edge of technology in two to three years time -...
An antifungal product in development at France's BioAlliance Pharma has been shown to treat a yeast infection in the mouth with similar efficacy but 10 times less drug than its nearest competitor, reports Phil Taylor.
Qiagen has released two protein purification kits that provide affordable automation as a way to increase throughput and free up valuable manpower for less routine tasks.
US generic company Able Laboratories ceased all its manufacturing and recalled products yesterday after major problems emerged with its quality control procedures, reports Phil Taylor.
Norbrook Laboratories of Northern Ireland has acquired two anaesthetic product lines and a production facility from Czech company Synthesia, part of the Aliachem group, reports Phil Taylor.
NextGen Sciences has launched an "automation-friendly" range of consumables, designed to maximise throughput and productivity for protein expression. The products have been designed to reduce error and increase expression effectiveness.
BioInvent become the latest company to enter the HIV/AIDS drug arena after UK authorities gave the go ahead to commence the company's first clinical trial of its human antibody to treat the virus.
GlaxoSmithKline is planning to use a series of packaging and on-tablet technologies to prevent parallel trade in its HIV drugs Combivir (zidovudine and lamivudine) and Epivir (lamivudine), writes Phil Taylor.